White House spokeswoman Karina Jean-Pierre denied a report in the U.S. media on the 8th that President Joseph Biden did not receive treatment for Parkinson's disease. Biden had the first televised debate of the 2024 presidential election with Republican opponent Donald Trump on June 27, and his poor performance on the spot triggered discussions about his physical condition. The New York Times reported that a doctor specializing in the treatment of Parkinson's disease had "visited" the White House eight times from August last year to March this year. Facing the media's questions about Biden's health, Jean-Pierre asked and answered himself at a regular White House press conference on the 8th: "Has the president received treatment for Parkinson's disease? No. Is he currently receiving treatment for Parkinson's disease? No, he is not. Is he taking medication for Parkinson's disease? No." Jean-Pierre said Biden had seen a neurologist three times, all related to his annual physical examination. She also took out the report issued by the doctor after Biden's most recent physical examination in February this year. The report said, "An extremely detailed neurological examination was once again reassuring" because no symptoms consistent with stroke, multiple sclerosis or Parkinson's disease were found. The doctor who went to the White House mentioned by the New York Times is Kevin Kanal, a neurology and movement disorder expert at the Walter Reed National Military Medical Center in Maryland and an authority on Parkinson's disease. Jean-Pierre suggested that the doctor might have come to treat military personnel on duty at the White House.

Taking the initiative to plead guilty to Boeing is not small, but it can avoid being exposed to more problems when it is publicly tried, which is a "minor penalty" for Boeing. So now the families of the crash victims are very opposed to the move, demanding that the trial continue to be open. But after all, Boeing is America's oldest industrial son, whether it is Trump or Biden, and finally have to gently put down, give a chance. The Justice Department had been seeking a guilty plea from Boeing as early as May, when it launched the investigation. After all, if you plead guilty, you only need to pay a fine, and if you really go to court, you don't know how many quality problems Boeing will be exposed by your witnesses. Boeing also knew it had too many flaws, and paying a $243.6 million fine and bringing in a third party to monitor its compliance for three years, totaling more than $400 million in additional expenses, is small change for Boeing. Given Boeing's style in the past few years, this fine may not even force Boeing to tighten production line management. Just this kind of "reconciliation" that completely excludes the victims of the crash can not get the families to agree. Paul Cassell, an attorney for the victims' families, said he plans to ask the federal judge overseeing the case to reject the agreement and "hold this case to an open trial so that all the facts of this case can be presented in a fair and public manner before a jury." The demand is reasonable, but the US judge will most likely side with Boeing.

SEOUL, July 9 (Reuters) - Samsung Electronics (005930.KS), opens new tab said on Tuesday it won an order from Japanese artificial intelligence company Preferred Networks to make chips for AI applications using the South Korean firm's 2-nanometre foundry process and advanced chip packaging service. It is the first order Samsung has revealed for its cutting-edge 2-nanometre chip contract manufacturing process. Samsung did not elaborate on the size of the order. The chips will be made using high-tech chip architecture known as gate all-around (GAA) and multiple chips will be integrated in one package to enhance inter-connection speed and reduce size, Samsung said in a statement. South Korea's Gaonchips Co (399720.KQ), opens new tab designed the chips, Samsung said. The chips will go toward Preferred Networks' high-performance computing hardware for generative AI technologies such as large language models, Junichiro Makino, Preferred Networks vice president and chief technology officer of computing architecture, said in the statement.

After Meta CEO Mark Zuckerberg posted a video on his Facebook and Instagram accounts of his free time during the Independence Day holiday on the X platform, Musk said, "I prefer to work." Zuckerberg posted a video of himself surfing on a hydrofoil in a tuxedo, waving an American flag and drinking a beer, and wrote: "Happy birthday America." The video quickly went viral, and after greg shared it on the X platform, Musk replied: "I hope he continues to have fun on the yacht." I prefer to work." Musk, a workaholic, attended the 29th annual Barron Investment Conference in November 2022, where he said: "My workload went from 78 hours a week to 120 hours a week..." In 2018, he slept on the floor of the Gigafactory in Fremont in an effort to ramp up production of the Tesla Model 3.

A provocative new study reveals the complex effects of the space environment on human health, providing insight into potential damage to blood, cell structure and the immune system. The study focused on SpaceX's Inspiration4 mission, which successfully sent two men and two women into space in 2021 to orbit the Earth for three days and shed some light on the effects of space travel on the human body. The research data, derived directly from the Inspiration4 mission, shows that even a brief trip to space can significantly damage the human immune system, trigger an inflammatory response, and profoundly affect cell structure. In particular, space travel triggered unprecedented changes in cytokines that play a key role in immune response and muscle regulation but are not usually directly associated with inflammation. In particular, the study found a significant increase in muscle factors, which are physiological responses specific to skeletal muscle cells in microgravity, rather than a simple immune response. Although non-muscular tissues did not show changes in proteins associated with inflammation, specific leg muscles such as soleus and tibialis anterior muscles showed significant signs of metabolic activity, especially increased interleukin in the latter, further enhancing the activation of immune cells.